A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, Cardiac Regeneration Start-Ups Look to Repair, not Replace, features profiles of Arteriocyte, Celladon, NanoCor Therapeutics and Theregen. Plus these Start-Up Across Health Care: Alder Biopharmaceuticals, Endotis, Novelix and VaxInnate.

For 15 years, its founders dreamed of starting a company to design new cancer drugs, but it wasn't until 2005 that they were able to lock up all the compounds they wanted. Novelix Pharmaceuticals now boasts a preclinical pipeline that's four candidates strong--all novel, proprietary, small molecules with innovative modes of action and favorable ADMET profiles.